广发纳斯达克生物科技C人民币(016470)
动态评分： 5.71分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | AMLX | Amylyx Pharmaceuticals Inc | 3.91 | 0.02% |
| 2024-12-31 | AVIR | Atea Pharmaceuticals Inc | 4.27 | 0.02% |
| 2024-12-31 | ARTV | Artiva Biotherapeutics Inc | 3.7 | 0.02% |
| 2024-12-31 | ALEC | Alector Inc | 2.91 | 0.02% |
| 2024-12-31 | CCCC | C4 Therapeutics Inc | 3.84 | 0.02% |
| 2024-12-31 | ACIU | AC Immune SA | 4.03 | 0.02% |
| 2024-12-31 | ITOS | iTeos Therapeutics Inc | 4.23 | 0.02% |
| 2024-12-31 | CMPS | COMPASS Pathways plc ADR | 2.9 | 0.02% |
| 2024-12-31 | SCPH | scPharmaceuticals Inc | 2.67 | 0.02% |
| 2024-12-31 | INBX | Inhibrx Biosciences Inc | 3.37 | 0.02% |
| 2024-12-31 | TVGN | Tevogen Bio Holdings Inc | 2.72 | 0.02% |
| 2024-12-31 | ACRV | Acrivon Therapeutics Inc | 2.83 | 0.02% |
| 2024-12-31 | NKTX | Nkarta Inc | 2.65 | 0.02% |
| 2024-12-31 | INZY | Inozyme Pharma Inc | 2.69 | 0.02% |
| 2024-12-31 | MGNX | MacroGenics Inc | 3.08 | 0.02% |
| 2024-12-31 | FATE | Fate Therapeutics Inc | 2.84 | 0.02% |
| 2024-12-31 | FHTX | Foghorn Therapeutics Inc | 3.96 | 0.02% |
| 2024-12-31 | EDIT | Editas Medicine Inc | 1.67 | 0.01% |
| 2024-12-31 | BMEA | Biomea Fusion Inc | 2.19 | 0.01% |
| 2024-12-31 | PYXS | Pyxis Oncology Inc | 1.4 | 0.01% |
公告&资料
